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Abstract
Intelligence quotient (IQ), has been found to relate to the presence of internalising symptoms in autism spectrum disorder 
(ASD). This meta-analysis sought to clarify the direction of the relationship between IQ and two prevalent internalising 
symptoms, anxiety and depression, in adolescents with ASD. Secondly, this study aimed to highlight methodological factors 
contributing to inconsistent findings in existing research. Self-reported anxiety was found to be significantly higher in youth 
with a lower IQ, while depression was positively associated with IQ. Consequently, parents, schools and clinicians should 
be cautious of underestimating anxiety in youth with a lower IQ. However, care should also be taken to ensure adolescents 
with ASD without intellectual disabilities are not overlooked with regards to social and emotional support.
Keywords Autism spectrum disorder · Adolescents · Anxiety · Depression · Intelligence quotient · Internalising symptoms
As awareness of both autism spectrum disorder (ASD) and 
mental illness has progressed, they have become increas-
ingly discussed in the academic and public sphere. This 
study seeks to further the understanding of the simultaneous 
presence of these conditions. Such knowledge is essential to 
improving the mental health of individuals with ASD, a cur-
rent priority for the ASD community (Povey 2016).
ASD encompasses a ‘spectrum’ of neurodevelopmen-
tal disabilities, replacing the separate diagnostic labels of 
Asperger syndrome, autistic disorder and pervasive develop-
mental disorder not otherwise specified. To differing extents, 
functions such as socialisation, flexible thinking and com-
munication are affected (American Psychiatric Association 
2013). These deficits have been linked to a host of psychi-
atric disorders, estimated to affect 70% of youth with ASD 
(Simonoff et al. 2008). They include internalising symp-
toms: emotional problems developed and largely maintained 
within the individual, such as depression, anxiety, fear, and 
low self-esteem (Merrell 2008; Ollendick and King 1994). It 
has been highlighted that depression and anxiety are particu-
larly prevalent in individuals with ASD (Ghaziuddin et al. 
2002; van Steensel et al. 2011).
Adolescence is known to be a period of vulnerability to 
depression and anxiety and this is no exception within the 
ASD population (Scherff et al. 2014). Anxiety is a dominant 
presenting problem for adolescents with ASD (Williams 
et al. 2015). Furthermore, research has found increased rates 
of anxiety in adolescents with ASD, compared to the general 
population (Vasa et al. 2013). In addition, adolescence is a 
time when youth transition between health service providers. 
A common fear for parents of youth with autism is that their 
children will be under-supported during this time (Weiss 
2008); both child and adult services must be well equipped 
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to provide mental health support for young people with 
autism. Moreover, psychiatric and behavioural disorders in 
youth with ASD have been shown to result in higher medi-
cal expenditure compared to those without ASD, which may 
cause caregiver-stress (McCarthy 2007). Hence, enhancing 
the knowledge and understanding of internalising symptoms 
in individuals with ASD during adolescence is valuable. It 
may aid parents, educational and health services in iden-
tifying those at higher risk and implementing prevention 
strategies, as well as adequately managing those affected. 
Addressing mental illness effectively during this period is 
vital, since it can benefit school performance, social devel-
opment, and behavioural outcomes in adulthood (McEwan 
et al. 2007; Murphy et al. 2015).
Research concerning internalising symptoms in people 
with ASD has highlighted intelligence as an important vari-
able. Intelligence is defined by intelligent quotient (IQ) for 
the purpose of this study, with intellectual disability defining 
an IQ score of below 70 (Luckasson et al. 2002). However, 
evidence regarding the correlation between IQ and depres-
sion or anxiety in individuals with ASD is conflicting. Nega-
tive, positive, non-linear and non-existent associations have 
all been reported, as outlined below.
Negative Correlation Between IQ 
and Internalising Symptoms
Prior studies have suggested that lower IQ relates to higher 
levels of internalising symptoms in young people with ASD 
(Amr et al. 2012; Rosa et al. 2016). Similarly, a previous 
meta-analysis found a negative correlation between IQ and 
anxiety in children and adolescents with ASD (van Steensel 
et al. 2011).
Some explanations for this negative association have been 
suggested. A lower IQ could cause poorer coping strategies, 
so that unfamiliar tasks induce anxiety (Crabbe 2001). Given 
this, a lower IQ may correlate with more emotional problems 
through adolescence, a time of unfamiliar experiences. By 
contrast, a higher IQ might allow for adaptive coping skills, 
such as seeking help when needed, shown to be associated 
with lower depression levels in youth with ASD (Pouw et al. 
2013).
A poorer ability to communicate feelings could also be a 
factor in the negative correlation between IQ and internalis-
ing symptoms. Difficulties in identifying and describing feel-
ings are involved in the personality trait alexithymia (Taylor 
et al. 1991). Milosavljevic et al. (2016) found that a lower 
verbal IQ was associated with higher levels of alexithymia 
in adolescents with ASD. Presence of alexithymia was also 
related to increased anxiety. Additionally, communication 
deficits associated with a lower IQ have been suggested 
to cause problems with conversing and dismissing fears 
(Pickersgill et al. 1994). Overall, difficulties in expressing 
feelings could result in individuals keeping their problems 
internalised and receiving inadequate support. Both of these 
factors may explain the observation of higher internalising 
symptoms in less intelligent youth with ASD.
Positive Correlation Between IQ 
and Internalising Symptoms
Conversely, several studies have reported a link between a 
higher IQ and depression in people with ASD (Fung et al. 
2015; Ghaziuddin and Greden 1998; Greenlee et al. 2016; 
Mayes et al. 2011a, b). A positive correlation between IQ 
and anxiety has also been observed (Gotham et al. 2015; 
Mayes et al. 2011a, b; Niditch et al. 2012; Sukhodolsky et al. 
2008).
Two explanations arise from this research. The first expla-
nation is that higher intelligence may indeed increase the risk 
for internalising symptoms in individuals with ASD. Several 
underlying mechanisms have been proposed; for instance, 
a lack of social support. Socialising is known to improve 
emotional health (Kawachi and Berkman 2001). Taylor and 
Seltzer (2011) compared the post-secondary school activi-
ties of youth with ASD during the transition to adulthood, 
with and without an intellectual disability. Those without an 
intellectual disability were 3 times more likely to have no 
daytime activities. Eighty-six percent of participants with-
out daytime activities had a comorbid psychiatric diagnosis, 
including anxiety or depression. One reason for a lack of 
social support may be that young people without significant 
intellectual disability are more likely to attend educational 
institutions with typically developing peers and the number 
of such pupils is increasing (Humphrey and Symes 2010). 
Compared to institutions that care for young people with 
disabilities, these institutions may place less emphasis on 
tailored social and emotional support. Furthermore, youth 
with ASD are at an increased risk of social exclusion by their 
school peers, which may also negatively impact emotional 
health (Humphrey and Symes 2010). Consequently, an inad-
equacy of social support for more intelligent youth could be 
one factor causing greater emotional difficulties.
Another proposed mechanism is that youth with a higher 
IQ may have greater social understanding, including an 
increased awareness of their own social competence and 
deficits, which may be emphasised to themselves when 
attending mainstream educational institutions. This has been 
suggested to cause anxiety and depression (Caamaño et al. 
2013; Kushki et al. 2013; Vickerstaff et al. 2007). In addi-
tion, an enhanced awareness of personal deficits in the pres-
ence of a higher IQ could increase vulnerability to low self-
esteem. In line with this suggestion, lower self-esteem has 
been observed in children with autism with an IQ of 80 or 
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above, compared to those with an IQ below 80 (Mayes et al. 
2011a, b). Although an internalising symptom itself, low 
self-esteem could also predispose to anxiety and depression.
The second, alternative explanation is that a higher IQ 
may provide individuals with greater means to report their 
emotional difficulties, over those with a lower IQ (Caamaño 
et al. 2013). Moreover, in less intelligent individuals who 
cannot express their problems, anxiety symptoms may be 
mistaken for communication deficits and resultantly under-
estimated (Davis et al. 2011). The ability to report symp-
toms may therefore confound the relationship between IQ 
and internalising symptoms.
Non‑Linear and No Correlation Between IQ 
and Internalising Symptoms
To add to this discrepancy in findings, a previous meta-
analysis suggested a quadratic relationship, such that youth 
with an IQ between 70–87 experience higher anxiety than 
others. However, tentative results meant further investigation 
was necessary to conclude this relationship (van Steensel 
et al. 2011). A subsequent study could not find a quadratic 
or a linear correlation between IQ and anxiety (Eussen et al. 
2012). Others have also reported no association between IQ 
and internalising symptoms (Gotham et al. 2015; Simonoff 
et al. 2008; Strang et al. 2012). The most obvious explana-
tion is that IQ is unrelated to internalising symptoms in indi-
viduals with ASD. However, methodological factors could 
be obscuring a significant correlation, some of which are 
suggested below.
Factors Contributing to Conflicting Findings
Using IQ as an index of intelligence could affect the cor-
relation found with internalising symptoms in the ASD 
population: IQ tests can underestimate intelligence in those 
with ASD (Nader et al. 2016). The IQ range used in studies 
could also impact the association found with internalising 
symptoms depending on whether higher or lower IQs are 
included. Individual studies, as well as the meta-analysis by 
van Steensel et al. (2011), have reported restricted sample 
IQ ranges as a limitation (Eussen et al. 2012; Strang et al. 
2012).
The psychometric instrument used to measure internal-
ising symptoms could also influence the correlation with 
IQ. Instruments are based on differing criteria, for example 
they do not always correspond with Diagnostic and Statis-
tic Manual of Mental Disorders (DSM) guidelines, limiting 
their comparability. Also, the majority of these measures are 
designed for typically developing youth (Vasa et al. 2013) 
and may vary in their ability to accurately assess internalis-
ing symptoms in people with ASD.
Existing studies suggest that grouping multiple internal-
ising symptoms, or even subtypes of a symptom, into one 
variable could mask differing associations with IQ.  Gotham 
et al. (2015) found a positive correlation between IQ and 
anxiety, but no association with depression. A previous 
meta-analysis found that the direction of the correlation 
between IQ and anxiety varied, depending on the anxiety 
subtype analysed (van Steensel et al. 2011).
In addition, psychiatric medication use within a sample 
may alter the level of internalising symptoms experienced 
and subsequently reported, thus affecting the correlation 
with IQ (Mazefsky et al. 2011), given that such medication 
aims to lessen anxiety and depression.
Varying accuracy both within and between self and car-
egiver-reported internalising symptoms may also impact 
findings. It is currently debatable as to whether caregiver-
reports provide reliable depictions of internalising symp-
toms in youth with ASD and further evidence is required. 
Indeed, a limitation of the previous meta-analysis by Van 
Steensel et al (2011) was the insufficient data to test whether 
informant (parent versus child) moderated the relationship 
between anxiety and ASD. They called for future research to 
test how anxiety frequency varies across informants. On the 
one hand, parents could underestimate emotional difficul-
ties in some children (Cosi et al. 2010; Muris et al. 1999). 
Capps and colleagues found that parents observed less sad-
ness and fear in children who reported lower perceived self-
worth, compared to children with higher self-worth. It is 
possible that more intelligent youth are able to engage in 
greater social interaction. While this may highlight their 
deficits and resultantly lower their self-worth, parents may 
only perceive positive social adjustment (Capps et al. 1995). 
On the other hand, parental anxiety can cause over-reporting 
of anxious symptoms in children (Bernstein et al. 2005). 
Nevertheless, there is evidence that parent-rated anxiety and 
depression are effective methods of assessment and compa-
rable to self-reports (Ozsivadjian et al. 2014; Sukhodolsky 
et al. 2008). As mentioned previously, youth with higher 
IQs may be more able to report their symptoms than those 
with lower intelligence. Additionally, research shows that 
fewer parent–child discrepancies of anxiety symptoms occur 
when children have a higher verbal IQ (Ooi et al. 2016). It 
has been suggested that using both parent and self-reports 
would provide a more representative measurement of inter-
nalising symptoms experienced by an individual with ASD 
(Ooi et al. 2016).
Finally, gender distributions and ages of samples may 
affect levels of internalising symptoms measured, and con-
sequently the correlation found with IQ in individuals with 
ASD. However, evidence pertaining to these factors is incon-
sistent. While some findings show no relationship between 
 Journal of Autism and Developmental Disorders
1 3
gender and depression or anxiety in people with ASD 
(Mayes et al. 2011a, b), Solomon and colleagues reported 
that female adolescents had higher internalising symptoms 
than males (Solomon et al. 2012). Also, anxiety and depres-
sion have been shown to increase as children with ASD grow 
older (Mayes et al. 2011a, b), but other research suggests 
there is no relationship between age and these symptoms 
(Strang et al. 2012). By focusing on adolescence, the current 
study aims to limit any significant effects of younger versus 
older age on the relationship between IQ and internalising 
symptoms.
Rationale and Aims
Ultimately, anxiety and depression are known to be common 
in both autism and adolescent populations; yet the relation-
ship between IQ and these internalising symptoms in indi-
viduals with ASD is not well understood. This meta-analysis 
seeks to contribute towards a better understanding of this 
relationship, in order to allow affected and high-risk youth 
to be more readily identified and supported in clinical prac-
tice, educational settings and at home. Furthermore, young 
people with better mental health outcomes are more likely to 
be able to positively contribute to society as adults.
Thus, the primary aim of this study is to synthesise the 
current evidence to distinguish the overall direction of the 
association between IQ and internalising symptoms in ado-
lescents with ASD. Secondly, this study aims to highlight 
methodological factors contributing to inconsistent findings 
in the existing literature, in order to assist in achieving the 
primary aim, as well as guide future research.
Anxiety and depression are investigated as separate out-
comes in this meta-analysis to account for differing asso-
ciations with IQ. Additionally, high rates of internalising 
disorders have been shown not only in individuals clinically 
diagnosed with ASD, but also in the broader population 
with ASD traits (Simonoff et al. 2008). This study therefore 
investigates youth across the autism spectrum, with or with-
out a clinical diagnosis.
Methods
This meta-analysis was completed following the Meta-anal-
ysis Of Observational Studies in Epidemiology (MOOSE) 
guidelines (Stroup et al. 2000).
Systematic Literature Search Strategy
An expert in systematic literature searching approved the 
following search strategy. The databases MEDLINE, Psy-
cINFO and Scopus were used to identify studies for this 
investigation. Search terms were selected, pertaining to four 
subjects: intelligence, internalising symptoms, ASD and 
adolescence. These four groups of search terms were sepa-
rated by the Boolean operator ‘and’, while ‘or’ was used to 
separate terms within each group. Resultantly, studies relat-
ing to all four groups were returned. Studies from the earliest 
record date of each database to 10/02/2017 were obtained. 
Appendix A contains the full list of search terms.
Eligibility Criteria and Study Selection Process
Specific eligibility criteria guided the selection of studies. 
Publications had to be empirical studies from peer-reviewed 
journals published in English. All other types of literature 
were excluded, such as books, book reviews, dissertations, 
meta-analyses and literature reviews.
Studies had to include an ASD sample. A finding for 
this sample on the association between IQ and internalising 
symptoms (anxiety and/or depression) was also required, 
with or without an effect size. The internalising symptoms 
could be subclinical or clinical.
Due to a lack of existing studies focusing solely on ado-
lescence, it was determined that the sample needed a mean 
age between 10.0–19.0 years at the time of assessment, in 
order to be defined as adolescent (WHO 2017) and included 
in the study. In some studies, data on IQ or internalising 
symptoms was missing for a minority of participants and 
there was no corrected mean age for the subset of the 
sample with data. The study was then included if it was 
deemed to be likely that the mean age would fall within 
10.0–19.0 years, based on the age information given and 
extent of missing data.
Following the above criteria, adolescent age, English 
language, human population and peer-reviewed journal 
article restrictions were imposed on searches within the 
databases where possible, to minimise manual exclusion of 
the retrieved studies. It was also outlined that if two or more 
studies used overlapping cohorts of participants, the article 
with the larger sample size or more necessary data reported 
would be included.
The publications received from the databases were man-
aged using Endnote. Duplicate publications were removed 
electronically and any remaining duplicates were deleted 
manually. Next, the specified eligibility criteria were applied 
to the titles and abstracts of the 672 non-duplicated studies. 
Full text articles were then obtained for a) studies that met 
all eligibility criteria b) studies that could not be shown to 
meet or fail eligibility criteria based on the title and abstract 
alone, to allow closer evaluation.
The authors of this study independently tested the pub-
lications against the eligibility criteria. Where there was 
uncertainty about whether a paper met the criteria for 
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inclusion, all three researchers discussed the paper until a 
decision was reached.
Efforts were made to ensure systematic inclusion of all 
relevant existing studies. The reference lists of the 167 full 
text articles were examined and five additional studies were 
identified that met the eligibility criteria. Furthermore, two 
studies were located from the 2016/17 issues of two reoccur-
ring journals from the systematic literature search: Autism 
and Journal of Autism and Developmental Disorders. The 
rationale for looking at these issues was based on newer 
articles not necessarily having been assigned Medical Sub-
ject Headings in the databases, increasing their risk of being 
missed in the search process.
From the 28 articles that met the eligibility criteria, 15 
studies were included in the meta-analysis, as they reported 
an effect size (whether significant or non-significant) for the 
relationship between IQ and depression/anxiety. Thirteen 
studies were excluded from the meta-analysis for three rea-
sons. Firstly, studies that investigated anxiety and depres-
sion as separate entities, but did not report an effect size 
or statistical information that could be used to calculate an 
effect size, were excluded. Secondly, the study by Hallett 
et al. (2013) was excluded, because the analysis software 
did not accept intraclass correlations. Thirdly, studies that 
grouped anxiety and depression together, with or without 
other symptoms, were excluded.
These 13 studies were included as appropriate in an anxi-
ety, depression, or grouped internalising symptoms vote-
counting procedure instead. Vote-counting involved totalling 
the number of studies reporting a positive, negative or no 
association between IQ and the internalising symptom(s). 
Although the current study set out to investigate anxiety 
and depression separately, articles that grouped internalis-
ing symptoms together were included in the vote-counting 
process to test the theory that the correlation is unclear when 
multiple symptoms are assessed as one variable. A meta-
analysis was not eligible to test this, because only two stud-
ies reported effect sizes and the symptoms grouped together 
differed between the two studies.
Figure  1 summarises the literature search and study 
selection process. The study characteristics of the 13 stud-
ies excluded from the meta-analysis are detailed in Table 1.
Data Extraction
For each study included in the meta-analysis, the following 
information was extracted: study size; age and gender dis-
tribution of the ASD sample; IQ test, score and range; type 
of internalising symptom (anxiety/depression); method of 
assessing internalising symptom, and method of confirm-
ing ASD status. Any details on whether participants were 
on psychiatric medication were also recorded. Furthermore, 
the correlation coefficient for the association between IQ and 
anxiety or depression was extracted from each study. Where 
no correlation coefficient was reported, alternative statistics 
that could be used to calculate an effect size were recorded 
(Table 2). In order to fulfil the methodological criteria that 
analyses cannot contain more than one effect size per study, 
three studies required a decision to be made regarding which 
statistic to extract. Appendix B outlines the rationales for 
the choices made.
Quality Assessment
A novel 5-point quality assessment score was designed for 
this meta-analysis, a concept taken from Bhutta et al. (2002). 
The quality criteria incorporated factors likely to influence 
the association between IQ and anxiety or depression, based 
on examination of existing literature.
Quality Criteria (Pass/Fail)
A. ASD sample recruited from same or similar populations 
(e.g. geographical area or clinical setting).
B. Established method of confirming ASD status (e.g. 
Autism Diagnostic Observation Schedule, Autism Diag-
nostic Interview, any DSM criteria).
C. No psychiatric medication use at time of assessment or 
steps taken to limit effect of medication on findings e.g. 
medication controlled for in analyses, or symptoms prior 
to medication use reported.
D. Established intelligence test for measuring IQ.
E. Established instrument used to asses internalising symp-
toms or professional diagnosis of internalising disorder.
‘Established’ refers to accepted psychometric measures 
in published literature, which have demonstrated reliabil-
ity. Studies scoring 4 or 5 were deemed of sufficient quality 
and therefore appropriate for inclusion in the meta-analysis. 
Scores of 4 were mainly due to studies not meeting criterion 
C. Consequently, psychiatric medication was included as a 
moderator and a sub-group analysis was performed to inves-
tigate whether medication status made a difference to the 
overall effect size. Due to a lack of information, two studies 
did not meet criteria C and D (Gadow et al. 2016; Ghaziud-
din and Greden 1998). They were deemed to be of a lower 
quality for use in this study, which was taken into account 
when interpreting the depression analysis results. Table 2 
specifies the study characteristics and quality scores for the 
meta-analysis studies.
Assessment of Heterogeneity, Publication Bias 
and Statistical Analyses
Statistical heterogeneity is a consequence of variability 
between studies, resulting from methodological differences 
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and clinical diversity, namely differences in participants 
(Deeks et al. 2008). Both types of variability between the 
studies included in the meta-analysis were evident from the 
data extraction and quality assessment processes.
Firstly, IQ tests varied between studies. For nine of the 
15 studies, versions of the Wechsler Scales were used. Other 
tests included the Stanford-Binet Intelligence Scale and 
Kaufman Brief Intelligence Test. Nevertheless, effect sizes 
obtained from these studies were considered comparable, as 
evidence supports high correlation between these IQ tests in 
people with ASD and general populations (Baum et al. 2015; 
Newton et al. 2008; Slate et al. 1996). All studies reported 
IQ or full-scale IQ scores; therefore scores were also deemed 
comparable.
Secondly, all studies used established methods of con-
firming ASD status. These methods were considered com-
parable, as congruence between them has been shown in an 
adolescent sample (de Bildt et al. 2004). Additionally, since 
the current study aimed to investigate how IQ relates to two 
internalising symptoms in a broad ASD population, varying 
measures for confirming ASD status were accepted. Finally, 
other evident sources of clinical and methodological hetero-
geneity were addressed using sub-group analyses.
Fig. 1  Flow chart showing the 
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Quantification of heterogeneity and all subsequent anal-
yses were carried out in Comprehensive Meta Analysis 
(CMA) software (Version 2.0). Assessment of heterogene-
ity was completed for the anxiety and depression outcomes 
separately. Higgins’ levels of heterogeneity informed the 
assessment, with an  I2 of 25%, 50% and 75% classified as 
low, moderate and high, respectively (Higgins et al. 2003). 
Table 1   Studies excluded from the meta-analysis and included in the vote-counting procedure
N = Autism sample size, IQ = Intelligence Quotient
a Obtained from reference lists of the 167 full text articles
b Obtained from key journal: Autism
NA Information not available, ASD Autism Spectrum Disorder, PDD Pervasive Developmental Disorder, AS Asperger Syndrome, HFA High 
Functioning Autism, HFASD High Functioning Autism Spectrum Disorder
DSM(-TR) = Diagnostic and Statistic Manual of Mental Disorders(-Text Revision), ADI(-R) = Autism Diagnostic Interview(-Revised), ADOS(-
G) = Autism Diagnostic Observation Schedule(-Generic), DAWBA = Development And Well-Being Assessment, ASSQ = Autism Spectrum 
Screening Questionnaire, ASAS = Australian Scale for Asperger’s Syndrome, KADI = Krug Asperger’s Disorder Index, DISCO = Diagnostic 
Interview for Social and Communication Disorders
WASI Wechsler Abbreviated Scale of Intelligence, SSC Simons Simplex Collection instruments for cognitive testing- no further information 
given, DAS Differential Abilities Scale, WISC(-R) Wechsler Intelligence Scale for Children(-Revised), FSIQ Full-Scale Intelligence Quotient, 
NVIQ Non Verbal Intelligence Quotient, VIQ Verbal Intelligence Quotient
c 11.5% participants with an IQ below 50 and 1.5% participants with an IQ above 130
d 3 participants with an IQ above 130
Grouped = Anxiety and depression grouped as one variable—plus or minus other psychological problems
CASI Child and Adolescent Symptom Inventory, K-SADS-PL Kiddie Schedule for Affective Disorders and Schizophrenia for School-Aged 
Children–Present and Lifetime, CBCL Child Behaviour Checklist, RCADS Revised Children’s Anxiety and Depression Scale, ADIS-C/P Anxi-
ety Disorders Interview Schedule-Child/Parent, BASC Behaviour Assessment System for Children, NASSQ Negative Affectivity Self-Statement 
Questionnaire, SCARED Screen for Anxiety and Related Emotional Disorders, OCHS-R Ontario Child Health Study-Revised, CDI Children’s 
Depression Inventory, CDRS-R Children’s Depression Rating Scale-Revised, RHSS Rochester Health Status Survey, KID-SCID Structured Clini-
cal Interview for Diagnostic and Statistical Manual-Version Four Childhood Disorders
% Male rounded to whole percentage, mean ages rounded to one decimal place, age ranges rounded to nearest year






IQ range Internalising symptom
(instrument)
Bitsika et al. 2016 150 100 11.2 (6–18) ASD (DSM-V) WASI-II (FSIQ) 73–132 Grouped (CASI)
Gjevik et al. 2011a 71 82 11.8 (6–18) ASD (ADI-R, DSM-
IV)
Leiter-R (NVIQ) 30–129 Anxiety, Depression
(K-SADS-PL)
Gotham et al. 2013 1429 86 10.2 (6–18) ASD (ADI-R, 
ADOS)
SSC (VIQ) 5–167 Anxiety (CBCL)
Hallett et al. 2013 141 85 13.5 (10–15) ASD (ADI-R, ADOS, 
DAWBA)
WASI (IQ) 50-130c Anxiety (RCADS)




67–158 Anxiety (ADIS-C/P, 
BASC-2, NASSQ, 
SCARED)
Kim et al. 2000 59 88 12.0 (9–14) PDD (ADI) Leiter, Stanford-
Binet-IV (IQ)
 > 68 Anxiety (OCHS-R)
Mazzone et al. 2013 30 100 11.1 (7–16) AS, HFA (ADOS-G, 
DSM-IV-TR)
WISC-III (FSIQ)  ≥ 85 Depression (CBCL, 
CDI, CDRS-R)
Meyer et al. 2006 31 84 10.1 (8–14) AS (ASSQ, ASAS) WISC-III (IQ) NA Grouped (BASC)
Rosa et al. 2016b 50 92 12.0 (7–17) HFASD (ADI-R) WASI-III, WISC-IV 
(IQ)
 ≥ 70 Grouped (K-SADS-PL)
Schroeder et al. 2011a 15 NA 12.1 (6–16) AS (DSM-IV, KADI) WASI (FSIQ) 89–141 Grouped (CBCL)
Taylor and Henninger 
2015
39 80 18.7 (17–22) ASD (ADI-R, 
ADOS)
Stanford-Binet (IQ) 40–137 Grouped (RHSS)
van Steensel et al. 
2013
40 90 11.1 (8–18) ASD (DSM-IV) WISC-R (IQ) 50-130d Grouped (KID-SCID)
Vickerstaff et al. 2007 22 86 11.9 (8–14) HFASD (DISCO) WASI (FSIQ) 82–141 Depression (BASC, 
CDI)
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Table 2   Studies included in the meta-analysis
N = Autism sample size relating to the effect size reported, IQ = Intelligence Quotient
a Obtained from reference lists of 167 full text articles
b Obtained from key Journal of Autism and Developmental Disorders, ASD Autism Spectrum Disorder, PDD Pervasive Developmental Disorder, 
AS Asperger Syndrome, NA Information not available, MF Male and female participants, DSM(-TR/R) Diagnostic and Statistic Manual of Men-
tal Disorders(-Text Revision/ Revised), CASI-4R 
Child and Adolescent Symptom Inventory-4Revised, ADOS(-G) Autism Diagnostic Observation Schedule(-Generic), ADI(-R) Autism Diagnos-
tic Interview(-Revised), AQ Autism-Spectrum Quotient-Adolescent Version, ASDS Asperger’s Syndrome Diagnostic Scale, SCQ Social Commu-
nication Questionnaire, ICD International Classification of Disease, SRS = Social Responsiveness Scale, WISC(-R) Wechsler Intelligence Scale 
for Children(-Revised), WASI Wechsler Abbreviated Scale of Intelligence, KBIT Kaufman Brief Intelligence Test, FSIQ Full-Scale Intelligence 
Quotient, ABIQ Abbreviated Battery Intelligence Quotient (reflects FSIQ), c IQ range for 75% of the sample, GAD Generalised Anxiety Dis-
order, CSBQ Children’s Social Behaviour Questionnaire, CAPA Child and Adolescent Psychiatric Assessment, CSHQ Children’s Sleep Habits 
Questionnaire, RCMAS Revised Children’s Manifest Anxiety Scale, SCAS-P Spence Children’s Anxiety Scale-Parent version, RCADS-P Revised 
Children’s Anxiety and Depression Scale-Parent version, CES-D Centre for Epidemiological Studies-Depression symptoms index, CBCL Child 
Behaviour Checklist, MASC Multidimensional Anxiety Scale for Children, P-ChIPS Children’s Interview for Psychiatric Syndromes-Parent ver-
sion, SD = Standard Deviation, r Correlation coefficient, t Independent t-test value, OR Unadjusted odds ratio, χ2 Chi-squared value
% Male rounded to whole percentage, mean ages rounded to one decimal place, age ranges rounded to nearest year
Study N Gender %
male






IQ range Internalising 
symptom—sub-
type (instrument)
Effect size data Quality score 
(failed crite-
rion)




10.9 (4–18) Autism (DSM-
III)
WISC-R (IQ) 36–70 Anxiety—fear 
of changes 
(CSBQ)
Mean, SD, N 4 (C)
Gadow et al. 
2016
214 81 10.4 (6–12) ASD (CASI-
4R, DSM-IV, 
ADOS)
NA (IQ)  ≥ 70c Depression 
(CASI-4R)
r 3 (C, D)
Ghaziuddin and 
Greden 1998
23 87 10.5 (≥ 7) Autism/PDD 
(DSM-III-R)
NA (FSIQ)  ≥ 50 Depression 
(DSM-III-R, 
Reiss scale)
Mean, SD, N 3 (C, D)
Hollocks et al. 
2014
52 100 12.9 (10–16) ASD (ADOS, 
ADI)
WASI (FSIQ) 76–138 Anxiety—any 
(CAPA)
Mean, SD, N 5









38 82 12.0 (10–17) Autistic/AS 
(ADOS-G, 
ADI-R)
WASI (IQ) 71–144 Anxiety—any 
(RCMAS)
r 5
Neil et al. 2016a 64 86 10.4 (6–15) Autistic (ADOS-
G, ADOS-2)





32 56 14.9 (12–17) ASD (AQ, 
ASDS)







67 87 11.2 (8–16) ASD (ADOS, 
SCQ)
WASI (FSIQ) NA Anxiety—any 
(SCAS-P)
Mean, SD, N 4 (C)
Simonoff et al. 
2008a
112 88 11.5 (10–14) ASD (ADOS-G, 
ADI-R, ICD-
10)
WISC-III (FSIQ) 19–124 Anxiety—any 
(CAPA)
OR 4 (C)



















17 90 12.1 (7–14) ASD (ADOS, 
SCQ)
NA (IQ) NA Anxiety—any 
(MASC)
t, N 4 (D)
Wigham et al. 
2015a











χ2, N 4 (C)
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Results determined which type of effects model would be 
used in the analyses: fixed or random.
For the 13 studies with an anxiety outcome, heteroge-
neity was moderately high  (I2 = 62.486%, Q(12) = 31.988, 
p < 0.01) To account for this, random effects models were 
used throughout all anxiety analyses. Moreover, heteroge-
neity results validated the decision to use sub-group analy-
ses to test whether each of seven moderators significantly 
explained the variance between IQ and anxiety levels. For 
each moderator,  I2 and corresponding Q measures of het-
erogeneity indicated the level of variance within each group 
under the moderator. Total Q between values  (Qbetween) spec-
ified the level of heterogeneity between groups, and conse-
quently whether the moderator had a significant effect. Since 
there were seven moderators for the sub-group analyses, a 
more stringent alpha value of 0.01 was used to indicate a sig-
nificant effect. This decision was made to limit the family-
wise error rate. Alternatively, a standard alpha value of 0.05 
was used to determine statistical significance of the main 
anxiety and depression analysis results.
For the four studies with statistical data on depression, 
heterogeneity was low  (I2 = 19.809%, Q(3) = 3.741). Result-
antly, a fixed effects model was used for the depression out-
come. Sub-group analyses were not run for depression, due 
to the low number of studies and low heterogeneity.
Publication bias was investigated for the studies on anxi-
ety and depression separately, using two methods. The fun-
nel plot method distributes effect sizes from each study 
around the pooled mean effect size. Asymmetrical distri-
bution visually indicates presence of publication bias. The 
trim-and-fill method estimates what the effect size would be 
without the presence of publication bias (Duval and Tweedie 
2000). This method was chosen over other alternatives, such 
as the fail-safe N, which has been advised against due to 
available methods producing widely varying estimations of 
bias (Sterne et al. 2008). Additionally, presence of bias due 
to lower reporting of non-significant effect sizes was inves-
tigated within the vote-counting procedure, which contained 
the studies excluded from the meta-analysis. It was predicted 
that the majority of the papers that did not provide effect 
sizes would report non-significant findings.
Selection and Coding of Moderators
For the anxiety sub-group analyses, seven moderators were 
chosen based on the rationales below. Table 3 describes how 
data were grouped and coded.
Person Reporting Anxiety
Caregiver and self-reports of anxiety were coded into two 
groups to test for the presence of discrepancies between 
the two methods of reporting anxiety, as found previously 
(Oswald et al. 2016), and whether this significantly affected 
the correlation with IQ. By incorporating this moderator, the 
current meta-analysis fulfilled the request of the previous 
meta-analysis, which asked for future studies to examine 
how anxiety frequency varies across informants (van Steen-
sel et al. 2011).
Psychiatric Medication
Psychiatric medication use could affect reports of anxiety 
(Mazefsky et al. 2011). The group labelled ‘Yes’ included 
studies with participants on medication, as well as the study 
by de Bildt et al. (2005). They reported that there was no 
exclusion of participants based on use of medication. The 
group labelled ‘No’ included samples not on any medication 
and studies that used analysis to prove no effect of medi-
cation on any reported findings (May et al. 2015; Strang 
et al. 2012). Additionally, Mazefsky et al. (2011) was coded 
‘No’, as participants were asked to report symptoms prior to 
receiving medication.
IQ Range
Studies were coded into three groups, depending on whether 
they included participants with: IQs of 70 or lower (≤ 70), 
IQs of 70 or higher (≥ 70), or IQs across these ranges 
(≤ 70 ≤). This was done to test whether the correlation found 
between IQ and anxiety may vary depending on the range of 
Table 3   Coding system for the seven moderators in the anxiety sub-
group analyses
Moderator Coding system for groups
Person reporting anxiety 0 = Self-reported
1 = Caregiver-reported
Psychiatric medication 0 = No
1 = Yes
IQ range 0 =  ≤ 70
1 =  ≥ 70
2 =  ≤ 70 ≤ 
Mean age 0 =  < 13.0 years
1 =  ≥ 13.0 years
Gender 0 = Male only
1 = Male and female
Effect size type 0 = r using continuous 
measurements of IQ and 
anxiety
1 = Effect size from IQ 
grouped participants
2 = Effect size from level of 
anxiety grouped partici-
pants
3 = Unadjusted odds ratio
DSM-IV-orientated anxiety assessment 0 = No/Unclear
1 = Yes
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IQs investigated. An IQ of 70 was used as a cut off based on 
the ranges specified by the studies. Note that one study stated 
no IQ range (Rodgers et al. 2012). However, they reported 
that all participants had IQs within the average range. Con-
sequently, the study was included in the ‘IQs of 70 or higher’ 
group. Also, in Vasa et al. (2013), despite no specified IQ 
range, the mean IQ (76.8) and standard deviation (23.7) were 
provided. Hence, it was inferred that participants with IQs 
above and below 70 were included and the study was coded 
accordingly.
Mean Age
By focusing on adolescence, this study anticipated limit-
ing any significant effects of younger versus older age on 
the relationship between IQ and internalising symptoms. 
However, there is some evidence that anxiety may increase 
through adolescence, perhaps due to the progressive devel-
opment of social awareness and self-perception (Mayes et al. 
2011a, b). Resultantly, eleven of the 13 study samples in the 
current study had a mean age of below 13.0 years and were 
grouped together. The two samples with a mean age above 
13.0 were categorised in a second group to test whether ear-
lier versus later adolescence significantly affected the asso-
ciation between IQ and anxiety.
Gender
Samples that included males and females were coded sepa-
rately from the male only sample. This was done to assess 
whether the male only sample was a significant source of 
heterogeneity that might impact findings on the association 
between IQ and anxiety.
Effect Size Type
The type of effect size reported in studies varied due to 
methodological differences in the way studies tested the 
correlation between IQ and anxiety. Four categories were 
used to test whether effect size type affected results of this 
meta-analysis. Studies coded ‘0′ reported correlation coef-
ficients (r) calculated using continuous measurements of IQ 
and anxiety. Code ‘1′ studies grouped participants based on 
IQ scores; hence the effect sizes reflected the difference in 
anxiety levels in youth with higher versus lower IQs. Stud-
ies coded ‘2′ separated participants based on anxiety levels, 
thus effect sizes reflected the difference in IQ for those with 
higher versus lower anxiety. Finally, Simonoff et al. (2008) 
used an unadjusted odds ratio, coded for separately as ‘3’.
DSM‑IV‑Orientated Anxiety Assessment
Studies were divided into two groups according to whether 
the instrument used to assess anxiety was based on DSM-IV 
criteria. This was done to address the heterogeneity between 
anxiety measures and test whether it had any significant 
effect on results. Nine of the 13 studies used DSM-IV-orien-
tated instruments, determining this method of grouping. The 
remaining four studies were coded into a second group for 
the following reasons. White and Roberson-Nay (2009) used 
the Multidimensional Anxiety Scale for Children, which is 
not completely congruent with DSM-IV criteria for anxiety 
(van Gastel and Ferdinand 2008). May et al. (2015) used the 
Children’s Sleep Habits Questionnaire, whilst de Bildt et al. 
(2005) used the Children’s Social Behaviour Questionnaire. 
For these instruments, it was uncertain whether the anxiety 
aspect (sleep anxiety and fear of changes, respectively) is 
assessed based on DSM criteria. Finally, Mazefsky et al. 
(2011) used the Revised Children’s Manifest Anxiety Scale, 
which does not clearly correspond with DSM-IV criteria 
(Lam et al. 2005).
Results
Anxiety: Main Analysis and Sub‑Group Analyses
The sample size across the 13 anxiety studies was 812. As 
per the forest plot (Fig. 2), the main analysis found no sig-
nificant association between IQ and anxiety, under a ran-
dom effects model (r = -0.015, p = 0.764). Person reporting 
anxiety was the only moderator significantly impacting the 
association between IQ and anxiety  (Qbetween(1) = 9.529, 
p < 0.01). Cohen’s (1988) guidelines were used to interpret 
the magnitude of significant correlations: r > 0.50 = large, 
0.50-0.30 = moderate, and 0.29-0.10 = small. Self-reported 
anxiety moderately negatively correlated with IQ (r = -0.424, 
p < 0.01), while there was no significant correlation between 
parent-reported anxiety and IQ. Table 4 shows the anxiety 
analyses results.
Depression Analysis
The sample size across the 4 depression studies was 364. 
Under a fixed effects model, a small positive correlation 
was found between IQ and depression (r = 0.119, p < 0.05) 
(Table 4). Figure 3 shows the forest plot for this analysis.
Publication Bias
Asymmetrical distribution of effect sizes in the funnel plots 
for both anxiety and depression indicated presence of pub-
lication bias. The trim-and-fill method provided estimations 
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Fig. 2  Forest plot showing a 
non-significant association 
between IQ and anxiety in 
adolescents with ASD, under 
a random effects model. The 
black circle for each study is 
proportional to the study’s 
weight in the anxiety analysis. 
The black diamond indicates 
















Statistics for each study Correlation and 95%CI
Lower Upper
Correlation limit limit Z-Value p-Value
0.287 0.050 0.493 2.362 0.018
-0.107 -0.361 0.162 -0.778 0.437
0.098 -0.198 0.378 0.645 0.519
-0.390 -0.631 -0.080 -2.436 0.015
0.010 -0.236 0.255 0.078 0.938
-0.054 -0.395 0.300 -0.291 0.771
-0.057 -0.288 0.180 -0.470 0.638
0.003 -0.004 0.010 0.784 0.433
-0.072 -0.266 0.128 -0.700 0.484
-0.060 -0.240 0.124 -0.636 0.525
-0.484 -0.751 -0.081 -2.317 0.020
-0.146 -0.410 0.141 -0.997 0.319
0.433 0.197 0.622 3.441 0.001
-0.015 -0.110 0.081 -0.300 0.764
-1.00 -0.50 0.00 0.50 1.00
Negativeassociation PositiveassociationNegative associat n P tive ass ciation
Table 4   Results of the meta-analysis examining the association between IQ and a) anxiety b) depression, in adolescents with ASD
CI Confidence Interval, k Number of studies, N Sample size across studies, r Correlation coefficient, LL Lower Limit, UL Upper Limit, Q & I2 
Heterogeneity within groups, Qbetween Heterogeneity between groups
p-values * <.05 ** <.01 *** <.001 
Superscript dot (.) indicates a statistically non-significant trend in the data (p<.1)
Outcome
(type of effects model)
Moderator 95% CI Heterogeneity
Groups k(N) r LL UL Q I2 (%) Qbetween
Anxiety (random) Without moderators (main analysis) 13(812) -.015 -.110 .081 31.988** 62.486
Person reporting anxiety: 9.529**
Self-reported 2(55) -.424** -.616 -.185 0.168 0.000
Caregiver-reported 11(757) .027 -.060 .113 20.546* 51.328
Psychiatric medication: 4.723*
No 5(248) -.162 -.341 .027 8.418 52.481
Yes 3(240) .219 -.098 .495 11.675** 82.870
IQ range: 5.761
 ≤ 70 1(67) .287* .050 .493 0.000 0.000
 ≥ 70 8(443) -.080 -.173 .015 6.021 0.000
 ≤ 70 ≤ 3(285) .102 -.117 .313 12.138** 83.523
Mean age: 0.114
 < 13.0 years 11(665) -.010 -.122 .103 31.454*** 68.207
 ≥ 13.0 years 2(147) -.059 -.220 .106 0.001 0.000
Gender: 0.258
Male only 1(52) -.107 -.361 .162 0.000 0.000
Male and female 12(760) -.008 -.110 .093 31.353** 64.915
Effect size type: 3.509
r using continuous measurements of IQ and anxiety 6(344) -.078 -.197 .043 5.979 16.373
Effect size from IQ grouped participants 3(142) .114 -.342 .527 14.306** 86.020
Effect size from level of anxiety grouped participants 3(214) -.076 -.207 .058 0.077 0.000
Unadjusted odds ratio 1(112) .003 -.004 .010 0.000 0.000
DSM-IV-orientated anxiety assessment: 0.211
No/ unclear 4(168) -.111 -.459 .266 17.288** 82.647
Yes 9(644) -.004 -.090 .083 14.678 45.497
Depression (fixed) Without moderators 4(364) .119* .017 .219 3.741 19.809
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of overall effects after adjusting for publication bias. Anxi-
ety remained non-significantly correlated with IQ (r = 0.044, 
95% CI [-0.056, 0.143]). For depression, the correlation with 
IQ became non-significant after adjustment (r = 0.094, 95% 
CI [-0.052, 0.192]). Figures 4 and 5 display these results. 
Finally, 8 of the 11 findings without effect sizes were 
reported as non-significant.
Fig. 3  Forest plot showing a 
positive association between IQ 
and depression in adolescents 
with ASD, under a fixed effects 
model. The black circle for 
each study is proportional to the 
study’s weight in the depression 
analysis. The black diamond 
indicates the overall effect 






Statistics for each study Correlation and 95%CI
Lower Upper
Correlation limit limit Z-Value p-Value
0.120 -0.014 0.250 1.752 0.080
0.425 0.064 0.688 2.284 0.022
0.141 -0.218 0.467 0.764 0.445
0.023 -0.177 0.220 0.220 0.826
0.119 0.017 0.219 2.275 0.023
-1.00 -0.50 0.00 0.50 1.00
Negativeassociation PositiveassociationNegative association Positive association
Fig. 4  Funnel plot for the 
anxiety publication bias analysis 
















= original overall effect size
= overall effect size after adjusting
for publication bias 
= effect size of each study 
included in the analysis 
Fig. 5  Funnel plot for the 
depression publication bias 
















= original overall effect size
= overall effect size after adjusting
for publication bias 
= effect size of each study 
included in the analysis 
= estimated location of
missing study 
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Vote‑counting Results
Table 5 shows the vote-counting results of the studies excluded 
from the meta-analysis. Eight of the 11 findings without effect 
sizes were reported as non-significant.
Discussion
This study aimed to synthesise the current evidence to dis-
tinguish the overall direction of the association between IQ 
and two prevalent internalising symptoms, depression and 
anxiety, in adolescents with ASD. It also sought to highlight 
methodological factors contributing to inconsistent findings 
in the existing literature, in order to assist in achieving the 
first aim, as well as guide future research. A meta-analysis 
was used to evaluate the relationship between IQ and (a) 
anxiety (b) depression, using effect sizes provided by 13 
and four studies, respectively. Before taking into account 
moderating factors, no significant relationship was found 
between IQ and anxiety (r = -0.015, p = 0.764). However, 
when only self-reported anxiety was considered, anxiety 
was moderately higher in less intelligent youth (r = -0.424, 
p < 0.01). This sub-group analysis result reflects the negative 
association found by a previous meta-analysis (van Steen-
sel et al. 2011). Furthermore, this study found a significant 
effect showing higher levels of depression in more intelligent 
youth (r = 0.119, p < 0.05), consistent with a recent study of 
1272 children and adolescents with ASD (Greenlee et al. 
2016).
Publication Bias
The trim-and-fill method estimated that the associations 
between IQ and the internalising symptoms would be non-
significant without the presence of publication bias (Figs. 4, 
5). These results are unsurprising, as non-significant find-
ings are less likely to be published and therefore included in 
this meta-analysis (Egger and Smith 1998). To put this issue 
into perspective, the studies excluded from the meta-analysis 
for not providing effect sizes were investigated within the 
vote-counting procedure. As predicted, the majority of these 
studies reported non-significant associations. Vote-counting 
results are discussed alongside the meta-analysis findings.
Anxiety Results
As expected, vote-counting showed that most of the studies 
excluded for lacking effect size data reported a non-signifi-
cant association between anxiety and IQ (Table 5), consist-
ent with the non-significant meta-analysis result. However, 
studies with lower sample sizes may have found effects that 
were too weak to detect and therefore deemed non-signifi-
cant. Had all of the studies reported effect sizes, they might 
have significantly affected the anxiety analysis result by con-
tributing towards a positive or negative correlation with IQ.
Combining the findings of the anxiety analysis and the 
vote-counting procedure, our results indicate that, before 
taking into account any moderating factors, IQ is unrelated 
to anxiety levels. However, the sub-group analyses identi-
fied a significant negative relationship between self-reported 
anxiety and IQ, providing a potential methodological reason 
Table 5   Vote-counting results of the studies excluded from the meta-analysis
a Included twice due to positive and negative correlations found between IQ and anxiety, depending on the anxiety subtype analysed and whether 
the anxiety was parent or self-rated
Internalising symptom Effect size 
reported
Correlation with IQ Number of 
studies
Studies
Anxiety Yes Positive 1 Hallett et al. 2013a
Anxiety Yes Negative 1 Hallett et al. 2013a
Anxiety No Positive 1 Gotham et al. 2013
Anxiety No Negative 0 n/a
Anxiety No Non-significant 3 Gjevik et al. 2011; Kerns et al. 2014; Kim et al. 2000
Depression No Positive 1 Vickerstaff et al. 2007
Depression No Negative 0 n/a
Depression No Non-significant 2 Gjevik et al. 2011; Mazzone et al. 2013
Grouped Yes Positive 2 Taylor and Henninger 2015; van Steensel et al. 2013
Grouped Yes Negative 0 n/a
Grouped No Positive 0 n/a
Grouped No Negative 1 Rosa et al. 2016
Grouped No Non-significant 3 Bitsika et al. 2016; Meyer et al. 2006; Schroeder et al. 2011
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for the non-significant result of the main anxiety analysis, 
as discussed below.
Sub‑Group Analyses
Seven moderators were tested to determine whether they 
significantly affected the association between IQ and anxi-
ety (Table 4).
Person reporting anxiety: Self versus caregiver-reported 
anxiety was the only significant moderator in the sub-group 
analyses  [Qbetween(1) = 9.529, p < 0.01]. This finding supports 
the existing concern of discrepancies between parent and 
self-reported internalising symptoms (Sterling et al. 2015).
Self-reported anxiety was moderately greater in adoles-
cents with lower IQs (r = -0.424, p < 0.01), challenging the 
notion that those with lower intelligence are less able to 
acknowledge and communicate symptoms than more intel-
ligent youth (Caamaño et al. 2013). It could also be that 
more intelligent individuals experience less anxiety, accu-
rately reflected in their reporting. The result highlights the 
importance of acknowledging variations in individual abili-
ties within ASD, rather than making assumptions based on 
IQ levels. While some adolescents with reduced intellectual 
abilities may be unable to communicate their emotions, this 
study shows others are capable. Consequently, caregivers 
and clinicians should establish the ability of an individual 
to self-identify symptoms, irrespective of their IQ, when 
assessing their mental health.
Conversely, caregiver-reported anxiety and IQ were not 
associated. It is possible that caregivers both underestimate 
and overestimate anxiety levels in youth with ASD, obscur-
ing the correlation with IQ. It is well established in litera-
ture that parents often underreport the anxiety experienced 
by their children (Cosi et al. 2010; Muris et al. 1999). By 
contrast, anxious parents have been shown to over-report 
anxiety in children (Bernstein et al. 2005). Furthermore, car-
egivers may overestimate or under-report anxiety by con-
fusing symptoms with ASD traits, such as communication 
deficits and social avoidance (Davis et al. 2011; Kuusikko 
et al. 2008). Also, parents of individuals with poorer abili-
ties to communicate feelings may struggle to accurately 
report anxiety symptoms, particularly if external signs do 
not accompany them. Caregiver under-reporting in less intel-
ligent youth may explain why higher self-reported anxiety, 
but not caregiver-reported anxiety, was found to relate to a 
lower IQ in the current meta-analysis. In line with this sug-
gestion, in the study by Hallett et al. (2013), greater anxi-
ety was associated with higher IQs when parent-rated, but 
when self-rated, it was associated with lower IQs. Thus, 
while measuring different anxiety subtypes might explain 
the divergence in findings, using different perspectives to 
report symptoms provides another explanation.
Ultimately, clinical heterogeneity between caregivers and 
amongst youth with ASD is inevitable and will affect the 
level of accuracy to which any particular caregiver reports 
anxiety. The current results suggest that caregiver and self-
reports should be used in combination to construct a more 
representative symptom profile. Additionally, parents should 
be cautious of underestimating anxiety levels in adolescents 
with lower IQs.
Psychiatric Medication
Psychiatric medication use did not significantly influence the 
relationship between IQ and anxiety. Mazefsky et al. (2011) 
suggested that psychiatric medication use limits studies 
investigating psychiatric problems. However, this finding 
implies that including individuals on psychiatric medica-
tion is not a major concern when assessing how IQ relates 
to anxiety in individuals with ASD. A large proportion of 
the ASD population take psychiatric medication (Mazefsky 
et al. 2011). Hence, the result is favourable to this meta-anal-
ysis and future studies, as excluding medicated individuals 
would restrict the range of youth eligible for investigation 
and reduce the generalisation of results to the broader ASD 
population.
IQ Range
The association between anxiety and IQ did not significantly 
differ depending on whether studies included participants 
with: IQs of 70 or lower, IQs of 70 or higher, or IQs across 
these ranges  [Qbetween(2) = 5.761, p < 0.1]. This contradicts 
the suggestion that studies analysing a wider IQ range might 
be more likely to find a significant relationship with emo-
tional problems (Fung et al. 2015).
Nevertheless, the results indicate a potential non-linear 
trend in the data, also found by the previous meta-analysis 
(van Steensel et al. 2011). For adolescents with IQs of 70 or 
lower, a small effect was found such that anxiety increased 
with IQ (r = 0.287, p < 0.05). Conversely, for those with IQs 
of 70 or above, there was a negative trend: anxiety increased 
as IQ decreased (r = -0.080, p < 0.1). In other words, within 
these two groups, anxiety was higher in participants with 
IQs closer to 70. No significant correlation was found for 
the group containing IQs above and below 70. Collectively, 
these findings tentatively indicate a quadratic relationship 
between IQ and anxiety.
One explanation is that it is possible for individuals with 
IQs nearing 70 or ‘borderline’ intellectual disability to be 
susceptible to risk factors for anxiety related to a lower IQ, 
as well as those associated with a higher IQ. For instance, 
they may have inadequate adaptive coping strategies and 
communication skills, which have been suggested to relate 
to higher anxiety in those with lower intelligence (Crabbe 
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2001; Pickersgill et al. 1994). Yet, a lack of severe cogni-
tive impairment increases their likelihood of integrating 
with typically developing youth and facing the challenge 
of keeping up academically and socially (Anderson et al. 
2011). They may also receive less social and emotional sup-
port than youth with more explicit intellectual disabilities, 
who may be prioritised by local services (Taylor and Seltzer 
2011) or more closely monitored by caregivers. Moreover, 
self-awareness of deficits has been suggested to cause anxi-
ety in people with ASD (Caamaño et al. 2013). Youth with 
borderline intelligence may have greater deficits than more 
intelligent individuals, coupled with more self-awareness 
than those with lower IQs, causing higher anxiety levels 
overall.
It should be noted that an IQ of 70 was used as a cut off 
based on the ranges used by studies; it is not necessarily 
the score at which the association changes if a non-linear 
correlation exists. The previous meta-analysis suggested an 
IQ between 70–87 was associated with higher anxiety, but 
only under a fixed effects model (van Steensel et al. 2011). 
Overall, the tentative findings of the current and previous 
meta-analyses provide reason for further investigation into 
the possibility of a middle ground IQ range at which indi-
viduals may be more susceptible to anxiety.
Mean Age
A sample mean age above versus below 13.0 years did not 
significantly affect the relationship between IQ and anxiety. 
Focusing on an adolescent population could have minimised 
any effect of younger versus older age on this investigation. 
Furthermore, during adolescence, the timings of factors that 
could induce anxiety vary from one individual to the next, 
for instance, the age at which youth reach puberty or develop 
self-consciousness. Age may, therefore, have no overall dis-
tinct association with anxiety in adolescents with ASD, as 
found by Strang et al. (2012). However, the small sample 
sizes limit the strength of this finding.
Gender
The association between IQ and anxiety did not significantly 
differ for the male only sample compared to the mixed gen-
der samples. This is unsurprising, as every sample included 
in the meta-analysis was over 50% male. This gender imbal-
ance is representative of the higher rate of identification 
of ASD in males compared to females (Fombonne 2009). 
Nevertheless, more research on how IQ relates to anxiety 
in females with ASD would allow clarification of whether 
current findings are relevant across genders.
Effect Size Type
Type of effect size, related to the way in which studies 
grouped participants, did not significantly affect the asso-
ciation between IQ and anxiety. This finding validates the 
decision of this meta-analysis to include studies with vary-
ing methodologies for measuring the association between 
IQ and anxiety.
DSM‑IV‑Orientated Anxiety Assessment
The relationship between IQ and anxiety did not signifi-
cantly differ depending on whether or not a DSM-IV-
orientated instrument for anxiety assessment was used. 
This finding suggests that measurements of anxiety using 
DSM-IV-orientated instruments are comparable to those 
that were potentially based on other criteria. It validates 
the decision of this meta-analysis to include studies using 
either type of instrument. Nonetheless, this was only one 
method of categorising heterogeneity between measures. 
Instruments could still vary in their ability to accurately 
assess anxiety in individuals with ASD, particularly since 
the majority are designed for the general population, such 
as the Child Behaviour Checklist (Vasa et al. 2013). This 
could affect accuracy, as signs of anxiety in those with 
ASD may differ from those shown by typically develop-
ing youth (Stern et al., 2014). Furthermore, questions that 
allow detection of anxiety in typically developing youth 
may not be appropriate for those with ASD, as found by 
Witwer and Lecavalier (2010). They administered the 
Children’s Interview for Psychiatric Symptoms, which 
asked some inapplicable questions, such as those relat-
ing to school grades. Resultantly, educational setting 
might have affected the measurement of anxiety obtained. 
More research into which instruments are most reliable at 
measuring anxiety in individuals with ASD would benefit 
the assessment of youth in future studies and in clinical 
practice.
Finally, although the current study was unable to mod-
erate for anxiety subtype due to a lack of studies with 
anxiety subtype data, it is worth noting that the term anx-
iety encompasses several disorders, such as generalised 
anxiety disorder, panic disorder, post traumatic stress dis-
order, social phobia and obsessive–compulsive disorder. 
The previous meta-analysis found that the relationship 
between IQ and anxiety differed, depending on the anxi-
ety subtype analysed (van Steensel et al. 2011). It could be 
that certain sources of anxiety are associated more closely 
with particular intelligence levels. For example, Hallett 
et al. (2013) observed greater parent-rated social anxiety 
in adolescents with higher IQs and greater self-rated sepa-
ration anxiety in those with lower IQs. They suggested 
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the former might be because more intelligent youth have 
a better social understanding and more concern regard-
ing fitting in among peers. Less intellectually able youth 
may require more support from caregivers, explaining the 
higher anxiety when separated from them.
Nevertheless, even when the associations between IQ 
and anxiety subtypes in individuals with ASD are investi-
gated, findings vary. Contrary to the above, higher social 
anxiety in less intelligent youth has been reported, pos-
sibly due to a lower awareness of social cues and greater 
difficulty adapting to social situations (Oswald et al. 2016; 
van Steensel et al. 2011). Also, a higher IQ has been asso-
ciated with increased separation anxiety (van Steensel 
et al. 2011). To further build on the understanding of how 
IQ relates to anxiety, further investigation into the asso-
ciations between IQ and anxiety subtypes, as well as the 
underlying mechanisms, is required.
Depression Results
For depression, only positive or non-significant associations 
with IQ were reported by studies in the vote-counting pro-
cedure (Table 5). These results are consistent with the lack 
of negative correlation shown by the meta-analysis, which 
found greater levels of depression in youth with higher IQs 
(r = 0.119, p < 0.05) and no association after adjustment for 
publication bias. Nevertheless, the effect that the findings of 
the excluded studies might have had on the meta-analysis, 
had they reported effect sizes, is uncertain.
Overall, results suggest that adolescents with lower IQs 
may be less susceptible to depression. Potential explanations 
include these individuals having more explicit disabilities, 
therefore receiving more robust social and emotional sup-
port than those with higher IQs, who are left to be more 
independent. Also, youth with lower IQs with a reduced 
self-awareness of deficits may be protected from low self-
esteem and associated depression (Mayes et al. 2011a, b). 
Conversely, adolescents with autism who are more able to 
perceive themselves as different from their peers have been 
shown to experience greater depression (Hedley and Young 
2006). The current results reiterate the importance of ade-
quate emotional support for youth with autism, including 
those with higher IQs.
However, the results also support the argument that 
depression is more accurately reported in the presence of 
a higher IQ. This could result from greater observance of 
symptoms by clinicians and caregivers, or a better ability to 
self-report feelings (Caamaño et al. 2013; Ghaziuddin and 
Greden 1998). Additionally, all but one study in this analysis 
used parent-reported depression. Thus, the inference drawn 
from the anxiety analysis that parents may underestimate 
symptoms in less intelligent youth might also be relevant to 
depression, although the current study cannot conclude this. 
A better insight into how depression can be detected in less 
intelligent youth is required to determine whether they may 
be at a similar risk to those with higher IQs.
Grouped Internalising Symptoms Results
Vote-counting results showed that, across the six studies, 
there was no overall agreement in the direction of the asso-
ciation between IQ and grouped internalising symptoms 
(Table 5). These results, alongside the meta-analysis results, 
validate the decision to analyse anxiety and depression sepa-
rately, by supporting the theory that relationships between 
different internalising symptoms and IQ in individuals with 
ASD may vary. The answer to why these relationships can 
differ is yet to be determined. One suggestion is that anxi-
ety might be somewhat alleviated through communication, 
particularly if the source of anxiety is known. Discussing 
worries and fears might be easier for those with a higher 
IQ (Pickersgill et al. 1994), causing them to report lower 
levels of anxiety, as found in this meta-analysis. Conversely, 
depressive symptoms may not be lessened by communica-
tion in the same way, especially if there is no external trig-
ger to talk through. This, amongst other factors, may cause 
more intelligent youth to be at a greater risk of depression 
than anxiety. This is in line with the current findings of high 
levels of depression in the presence of a higher IQ. With the 
directions of the associations between IQ and the two preva-
lent internalising symptoms in adolescents with ASD now 
further established, a clearer understanding of the mecha-
nisms underlying the relationships is needed to shed light 
on why they may differ.
Limitations
There are several limitations in this study. Firstly, anxiety 
subtypes (such as generalised anxiety disorder, panic disor-
der, post traumatic stress disorder, social phobia and obses-
sive–compulsive disorder) could not be assessed and some 
of the moderator groups were small. Secondly, having only 
four depression studies meant sub-group analyses were not 
possible. If the non-significant effect of psychiatric medica-
tion on anxiety analysis results was extrapolated to depres-
sion, the two papers that did not meet the current criteria for 
inclusion would have otherwise been included. As a result, 
the anxiety sub-group analyses findings may not be the same 
for depression.
Thirdly, the existing literature lacks studies focusing on 
groups with a low IQ; only four out of the 13 anxiety studies 
included in this meta-analysis stated that they incorporated 
youth with below-average IQ. A further 3 studies did not 
report IQ ranges (Table 2); one such study reported that all 
participants had IQs within the average range (Rodgers et al. 
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2012), while White and Roberson-Nay (2009) used a mean 
IQ of 92.24. However, Vasa et al. (2013), reported mean IQ 
of 76.8 suggesting youth with lower IQ were included in the 
study. Individuals with autism and intellectual disability is 
an understudied population within the autism spectrum (Jack 
and Pelphrey 2017). Similarly, when studying ASD one of 
the limitations of many studies, including those incorporated 
in the current meta-analysis, is the inherent sex bias where 
more males are diagnosed with this condition compared to 
females (Lai et al. 2013).
Finally, due to a lack of previous studies using solely ado-
lescent-aged samples, this meta-analysis had to implement 
an inclusion criterion whereby studies with mean age 10–19 
were accepted. However, this study provides an important 
start in addressing this research gap and contributing to the 
understanding of mental health problems commonly faced 
within the adolescent autism population specifically, which 
future research must continue to do.
Strengths and Key Findings, Including Implications 
for Future Research and Clinical Practice
Fulfilling its primary aim, this study synthesises the cur-
rent evidence to distinguish the overall direction of the 
association between IQ and two prevalent internalising 
symptoms, anxiety and depression, in adolescents with 
ASD. The results, summarised below, provide a clearer 
understanding of the relationship between these symp-
toms and IQ. It is hoped that the findings from this study 
will contribute towards allowing youth to be more readily 
identified and supported in clinical practice, educational 
settings and at home.
In agreement with a study of 1,272 youth with ASD, 
this meta-analysis has found that a higher IQ relates to 
greater levels of depression (Greenlee et al. 2016). Thus, 
in clinical practice, due to an increased risk of depression, 
care should be taken to ensure that youth with ASD with-
out intellectual disabilities are still provided with adequate 
social and emotional support.
The anxiety meta-analysis indicates that youth with a 
lower IQ experience higher anxiety when self-reported. 
The previous meta-analysis also found a negative correla-
tion between IQ and anxiety in ASD (van Steensel et al. 
2011). However, a limitation of that study was the insuf-
ficient data to test whether informant (parent versus child) 
moderated the relationship between anxiety and ASD. The 
sub-group analyses in the current study fulfils the request 
by Van Steensel et al (2011) asking future research to 
examine how anxiety frequency varies across inform-
ants. Furthermore, as per the second aim of the study, it 
highlights a key factor contributing to discrepancies in 
existing evidence on this topic: use of self or caregiver-
reported symptoms. In line with tentative findings from 
Van Steensel et al (2011), the current sub-group analyses 
also showed that individuals with ASD and ‘borderline’ 
intellectual disability may be particularly susceptible to 
anxiety Within clinical practice, it is important that the 
ability of adolescents with ASD to self-identify and report 
internalising symptoms is established, irrespective of their 
IQ, when their mental health is being assessed. Parents and 
clinicians should be cautious of underestimating anxiety 
in individuals with a lower IQ, who may themselves report 
significant symptoms. Overall, the congruity of the results 
from the current anxiety and depression meta-analyses 
with large previous studies aid in establishing the previ-
ously unclear directionality of the relationships between 
internalising symptoms and IQ in ASD.
As discussed above, the study has shown a significant 
positive relationship between depression and IQ, and a sig-
nificant negative relationship between self-reported-anxi-
ety and IQ, proving a need to assess different internalising 
symptoms separately, a strength of the current meta-analysis. 
To add further clarity, future studies should separate anxiety 
into subtypes.
Finally, this meta-analysis has highlighted understudied 
groups: future research should focus specifically on females, 
the adolescent age group and youth with a low IQ to ensure 
they are not neglected, as we continue to improve our under-
standing and treatment of the mental health concerns preva-
lent within the adolescent autism population.
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Appendix A
Complete List of the Search Terms Used Across 
the Databases: MEDLINE, PsycINFO and Scopus
Medical Subject Headings
Asperger syndrome OR autism spectrum disorder OR autis-
tic disorder OR autistic thinking OR exp autism spectrum 
disorders AND anxiety disorders OR exp anxiety disorders 
OR agoraphobia OR anxiety, separation OR obsessive–com-
pulsive disorder OR panic disorder OR phobic disorders 
OR depressive disorder OR depressive disorder, major OR 
depression (emotion) OR major depression OR sadness 
AND adolescent development OR child development OR 
childhood development OR adolescent OR child AND intel-
ligence tests OR stanford-binet test OR wechsler scales OR 
intelligence OR intelligence quotient OR exp intelligence 
measures OR intellectual development disorder OR intel-
lectual disability.
Note: ‘exp’ refers to exploded Medical Subject Headings, 
which include all the narrower search terms in the hierarchi-
cal list.
Keywords (in title or abstract)
Autis* OR asperger AND anxiety OR anxious OR fear OR 
depress* OR sad OR withdraw* OR internalising OR inter-
nalizing AND adolescen* OR child* OR youth OR teenage* 
AND IQ OR “intellectual ability” OR ID OR “intellectual 
disability” OR “cognitive ability” OR “learning disability” 
OR “mental retardation”.
Note: the asterisk (*) indicates that the search term 
includes the stem specified, but allows for different endings.
Appendix B
Rationales for Choice of Effect Size Extracted From 
Studies Reporting more than one Effect size
Witwer and Lecavalier (2010): Four chi-squared statistics 
for the association between IQ and anxiety were reported. 
Three statistics related to generalised anxiety disorder sub-
scores for: ‘worry more’, ‘hard to relax when worried’ and 
‘trouble letting go of worries’. One statistic related to a 
‘fear keeps from school’ phobia score. The effect size for 
‘worry more’ was chosen, as it was deemed to best reflect 
the definition of anxiety.
Oswald et al. (2016): For the anxiety analysis, the ‘total 
anxiety’ score was chosen as the outcome over anxiety 
subtype scores. Also, the parent-reported total anxiety 
score was used instead of the self-reported score. These 
decisions were both made to increase the homogeneity 
of studies in the meta-analysis, as most studies used par-
ent-reports of any anxiety. Similarly, for the depression 
analysis, parent-reported depression was used rather than 
self-reported depression to increase homogeneity of stud-
ies in this analysis.
Simonoff et al. (2008): The male and female statistic 
was chosen instead of the male only statistic, due to the 
larger sample size and for consistency with most studies 
included in the anxiety analysis.
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